According to the latest epidemiological survey data[1],the global prevalence of chronic kidney disease(CKD) has reached 9.1%, the total number of patients as high as 700 million.The prevalence rate in China is about 10.8%, with a total population of 132.3 million[2].CKD is projected to become the fifth most common risk factor for life expectancy impairment worldwide by 2024[3]. As the disease progresses and renal impairment worsens[4], CKD progressed to end-stage renal disease (ESRD)when the glomerular filtration rate (eGFR) was ≤ 20 mL/min/1.73 m2.ESRD patients need renal replacement therapy(dialysis or renal Transplantation, RRT) to maintain normal function, and More than 1.4 million people worldwide receive RRT[5].
Although RRT provides alternative support for the survival and development of patients with advanced renal disease, it is also highly invasive and injurious to patients[6]. The UK Kidney Registry study showed that RRT has a five-year survival rate of just 35% for those aged 64 to 74, and less than 20% for those over 75[7]. After long-term dialysis treatment, patients suffer from pain, fatigue, nausea, anorexia, insomnia and other symptoms, and their nutritional status and physical function are adversely affected, followed by anxiety, depression and other negative emotions[8]. Elderly patients with ESRD who receive dialysis treatment for a long time will have varying degrees of cognitive dysfunction, and their physical function and nutritional status will deteriorate[9].In the meanwhile, ESRD patients need long-term maintenance treatment, and the medical cost is high, which brings heavy economic burden to patients and their families[10].Especially for the elderly patients with ESRD and patients who can no longer tolerate dialysis treatment, the standard of living and quality of life are significantly negatively affected.For patients over 80 years of age,the survival benefits of dialysis do not outweigh the benefits of active supportive care and comprehensive symptom management[11]. In the meanwhile,studies have shown that active supportive care for elderly patients or those who have undergone long-term dialysis treatment and do not want to continue have positive significance for improving the quality of life of patients with end-stage renal disease[12].
In recent years, there has been a gradual increase in the research on kidney supportive care with more emphasis on alleviating the pain of the disease and improving the quality of life in late stage[13, 14].With the development of patients' prognostic awareness, palliative consciousness and shared decision making, kidney supportive care(KSC)provides a new treatment option for patients with ESRD.KSC is primarily for patients with advanced kidney disease for all causes or for any type of dialysis, who may have acute kidney injury or have undergone kidney replacement therapy[15]. It is a primary palliative care method jointly provided by nephrologists and nurses, palliative care specialists and multidisciplinary teams, with the main purpose of alleviating clinical pain, improving quality of life at the end of life, and providing symptom-based supportive care for patients with advanced renal disease[16].The kidney supportive care includes the decision to withdraw from dialysis based on shared decision-making with the patient and family, followed by the provision of active clinical symptom management, detailed prognosis communication, advanced care planning and end-of-life care palliative planning, and comprehensive psychosocial and spiritual support[11, 17].
At present, the application of KSC is mainly concentrated in Canada, the United States, Australia, New Zealand, but the application in China is limited[18].The project has not been well integrated into the hospice care of ESRD patients at present. Due to the lack of sound policy support and relevant skills training and economic security measures [19], the development of KSC in China is relatively late, and the application of palliative care is also less. Its application in China has only been explored in Hong Kong and Taiwan[20], but there is little relevant studies in mainland.
However, it is vital to assess attitudes and perceptions about the acceptability and feasibility of this strategy before promoting its widespread acceptance among Chinese patients, nephrologists, nursing workers, and policy makers.Therefore, this study used qualitative interview to explore the views and opinions of nephrologists, nurses and dialysis patients in China, and to explore the promotion and implementation of factors and obstacles in China, so as to better advocate KSC.